|
2024
|
Invention
|
Composition of selected tumor infiltrating lymphocytes and related methods of producing and using... |
|
2023
|
Invention
|
Recombinant vaccinia virus encoding one or more natural killer cell and t lymphocyte inhibitors. ... |
|
|
Invention
|
Compositions and methods for generating neo-antigen reactive tumor infiltrating lymphocytes. Vari... |
|
|
Invention
|
Modified orthopoxvirus vectors.
The disclosure relates to modified orthopoxvirus vectors, as wel... |
|
2022
|
Invention
|
Methods for ex vivo enrichment and expansion of tumor reactive t cells and related compositions t... |
|
2020
|
Invention
|
Method of producing tumor-reactive t cell composition using modulatory agents.
Provided herein a... |
|
|
Invention
|
Methods for inducing an immune response against neoantigens.
Provided herein is a method for ind... |
|
|
Invention
|
Methods for inducing an immune response against neoantigens. Provided herein is a method for indu... |
|
|
Invention
|
Ex vivo methods for producing a t cell therapeutic and related compositions and methods.
Provide... |
|
|
Invention
|
Methods for producing autologous t cells useful to treat cancers and compositions thereof.
Provi... |
|
2019
|
Invention
|
Modified orthopoxvirus vectors. The disclosure relates to modified orthopoxvirus vectors, as well... |
